EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation

Rabia Ülkü Korkmaz iD, Jimmy Omony, Xiaomei Tan, Markus Klotz, Guilherme Dragunas iD, Sirui Chen, Soni Shankhwar, Zeynep Ertüz, Christoph Müller, Mohab Ragab, Aicha Jeridi, Romina Augustin und 5 weitere

Allergy · 2025

DOI: 10.1111/all.70121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2025. Verfasst von Rabia Ülkü Korkmaz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Zentrum München, Research Center for Environmental Health, Institute of Asthma and Allergy Prevention, Neuherberg, Germany. Hauptthemen laut MEDLINE: Dust, Asthma, Eosinophilia, Eosinophils. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Center for Lung Research (DZL), Federal Ministry of Education and Research, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Asthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side effects highlight the need for additional therapeutic strategies. Environmental exposures such as traditional farm dust have been linked to protection against asthma and allergies. This study investigated the therapeutic potential of farm dust extract (FDE) in a murine model of allergic asthma when administered after sensitization and during allergen challenge, mimicking a secondary prevention or early interventional treatment approach.

Methods

We used an ovalbumin (OVA)‐induced asthma model to evaluate FDE effects on airway eosinophilia, airway hyperresponsiveness (AHR), mucus production, and IgE levels. Mechanistic studies assessed regulatory T cells (Tregs), dendritic cell phenotype, epithelial barrier integrity, and cytokine signaling. Complementary experiments were performed in peripheral blood mononuclear cells (PBMCs) from asthmatic donors.

Results

FDE significantly reduced airway inflammation and AHR, with secondary prevention effects comparable to systemic dexamethasone. FDE enhanced Treg frequency and CTLA‐4 expression, modulated dendritic cell MHC‐II and PD‐L1 expression, and promoted an immunoregulatory environment. It also restored epithelial barrier integrity and increased IL‐33 release, supporting Treg activation. In asthmatic PBMCs, FDE increased Tregs, reduced Th2 cells, and suppressed CIITA , suggesting similar immune‐regulatory effects. Interactions among IL‐33, amphiregulin (AREG), and Tregs highlighted a mechanism reinforcing immune‐epithelial homeostasis.

Conclusion

FDE administered after sensitization and during allergen challenge mitigated key asthma features in mice and showed translational potential in human cells, supporting its development as a novel, environmentally derived immunomodulatory strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DustAsthmaEosinophiliaEosinophilsAnimalsDisease Models, AnimalMiceT-Lymphocytes, RegulatoryAllergensCytokinesFemaleHumansInflammationOvalbuminFarms

Stichwörter der Autor:innen

Th2 inflammationasthmaepithelial barrierfarm dust extractprophylactic interventionregulatory T cells

Substanzen

DustAllergensCytokinesOvalbumin

Autor:innen und Institutionen

  • Helmholtz Zentrum München, Research Center for Environmental Health, Institute of Asthma and Allergy Prevention, Neuherberg, Germany.
  • Comprehensive Pneumology Center (CPC-M), Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Munich, Germany.
  • Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians Universität München, Munich, Germany.
  • Department of Internal Medicine II, TUM University Hospital, Klinikum Rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • German Center for Lung Research (DZL), Munich, Germany.
  • Helmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.

ORCID-Profile: Rabia Ülkü Korkmaz, Guilherme Dragunas, Ali Önder Yildirim

Förderung

  • German Center for Lung Research (DZL)
  • Federal Ministry of Education and Research
  • European Research Council
  • Deutsches Zentrum für Lungenforschung
  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Korkmaz, R. Ü., Omony, J., Tan, X., Klotz, M., Dragunas, G., Chen, S., Shankhwar, S., Ertüz, Z., Müller, C., Ragab, M., Jeridi, A., Augustin, R., Nawroth, J., Kapellos, T. S., Rankl, B., Yildirim, A. Ö., & von Mutius, E. (2025). The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation. Allergy. https://doi.org/10.1111/all.70121

Vancouver

Korkmaz RÜ, Omony J, Tan X, Klotz M, Dragunas G, Chen S, et al. The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation. Allergy. 2025. doi:10.1111/all.70121

BibTeX
@article{Korkmaz2025,
  author = {Korkmaz, Rabia Ülkü and Omony, Jimmy and Tan, Xiaomei and Klotz, Markus and Dragunas, Guilherme and Chen, Sirui and Shankhwar, Soni and Ertüz, Zeynep and Müller, Christoph and Ragab, Mohab and Jeridi, Aicha and Augustin, Romina and Nawroth, Janna and Kapellos, Theodore S and Rankl, Bettina and Yildirim, Ali Önder and von Mutius, Erika},
  title = {The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.70121}
}
Kostenlos starten →